Rolf Schürmann

Title: Rolf Schürmann: Innovator in Pharmaceutical Compositions

Introduction

Rolf Schürmann is a notable inventor based in Teltow, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in emergency contraception and hormone replacement therapy. With a total of 4 patents to his name, Schürmann's work has the potential to impact many lives.

Latest Patents

One of Schürmann's latest patents is a pharmaceutical composition for emergency contraception. This invention relates to the use of levonorgestrel in combination with COX inhibitors for the preparation of effective pharmaceutical compositions. Another significant patent involves very low-dosed solid oral dosage forms for hormone replacement therapy (HRT). This invention concerns a dosage form comprising about 0.5 mg estradiol and about 0.25 mg drospirenone, along with at least one pharmaceutically acceptable excipient. Despite the low doses, it has been found that a high proportion of women suffering from moderate to severe hot flushes respond positively to this treatment.

Career Highlights

Rolf Schürmann is currently associated with Bayer Intellectual Property GmbH, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving women's health through effective medication.

Collaborations

Schürmann has collaborated with notable colleagues such as Stephan Mletzko and Bernhard Lindenthal. These partnerships have likely contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Rolf Schürmann's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare solutions. His patents in emergency contraception and hormone replacement therapy highlight his role as a significant inventor in the field.